Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Receives Approval for Dupixent® in Japan for COPD Treatment

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted marketing and manufacturing authorization for Dupixent® (dupilumab) to treat chronic obstructive pulmonary disease (COPD) in adults whose condition is not well-managed with existing therapies. This …

Team Kalkine | 28 March 2025

Pony.ai (NASDAQ: PONY) Expands Paid Driverless Robotaxi Operations in Shenzhen

Pony.ai (NASDAQ: PONY) achieved a significant milestone on March 27, 2025, as the first company authorized to operate paid fully-driverless robotaxi services in Shenzhen's Nanshan District. This marks a key moment in the city's progress toward offering autonomous ride-hailing services in its urban centers.

Team Kalkine | 28 March 2025

Market Update: Tariffs Spark Sell-Off, Treasury Yields Rise, and Bitcoin Gains

The Trump administration's 25% tariff on non-US-made cars, set for April 2, sparked concerns about economic impact and inflation, triggering a market sell-off. General Motors fell over 6%, Ford dropped 1.8%, while Tesla gained nearly 1% due to its US-based production. Other major tech …

Team Kalkine | 27 March 2025

Yiren Digital Forms Strategic Joint Venture to Advance AI-Driven Financial Solutions in Southeast Asia

Yiren Digital Ltd. (NYSE:YRD)has announced the establishment of a strategic joint venture (JV) in Indonesia in collaboration with PT. Pinjaman Kemakmuran Rakyat ("klikUMKM") and PT. Artha Digital Investama, a subsidiary of Artha Graha Network (AG Network). This initiative is set to enhance digital financial …

Team Kalkine | 27 March 2025

Innate Pharma Reports 2024 Financial Results and Clinical Advancements

Innate Pharma SA (Nasdaq:IPHA)has announced its financial results for the year ending December 31, 2024, alongside notable advancements in its clinical pipeline. The company continues to make progress in immuno-oncology, securing regulatory recognition and funding to support ongoing research efforts.

Team Kalkine | 27 March 2025

IFF and Kemira Launch Alpha Bio to Advance Biobased Materials

IFF (NYSE:IFF) and Kemira have announced the establishment of Alpha Bio, a joint venture focused on scaling up the production of renewable biobased materials. With a planned investment of approximately €130 million, the new facility will begin operations in late 2027, converting up to …

Team Kalkine | 27 March 2025

Greenland Technologies Reports Turnaround in 2024 Financial Results, Operational Efficiency and Cost Reductions Drive Profitability

Greenland Technologies Holding Corporation (Nasdaq:GTEC) has announced its audited financial results for the fiscal year ending December 31, 2024, highlighting a significant improvement in profitability driven by cost reductions and enhanced operational performance.

Team Kalkine | 26 March 2025

Market Snapshot: Key Updates on Stocks, Commodities, and Economic Trends

President Trump reaffirmed his stance against excessive exceptions on reciprocal tariffs, set for April 2nd. Investors focused on upcoming durable goods orders. In premarket trading, Apple, Amazon, and Meta saw modest gains, while Microsoft remained flat. Nvidia, Alphabet, and Tesla declined.

Team Kalkine | 26 March 2025

Hoth Therapeutics (NASDAQ: HOTH) Advances Antisense Oligonucleotide Cancer Drug Candidate HT-KIT

Hoth Therapeutics, Inc. (NASDAQ: HOTH) has announced significant progress in the development of its proprietary antisense oligonucleotide (ASO) drug candidate, HT-KIT. The biopharmaceutical company is focused on creating therapies for allergic and inflammatory diseases, and HT-KIT represents an innovative approach to treating conditions such …

Team Kalkine | 26 March 2025

V2X (NYSE: VVX) Awarded Bridge to Enduring Synthetic Training Environment Contract with U.S. Army

V2X Inc. (NYSE: VVX) has been selected as a winner for the Bridge to Enduring Synthetic Training Environment Tactical Engagement Simulation Systems (TESS) Multiple-Award Contract (BEST MAC) Lot 1. This contract is a key component of the U.S. Army’s live training capabilities, as it …

Team Kalkine | 26 March 2025
Support

Hi! How can we help you today?

Loading…